O-5 Efficacy and safety of nivolumab + ipilimumab in Asian patients with advanced hepatocellular carcinoma: Subanalysis of the CheckMate 040 study — Thomas Yau (2020) | RDL Network
Bruno Sangro, Aiwu Ruth He, Thomas Yau, Chiun Hsu, Yoon‐Koo Kang, Tae‐You Kim, Armando Santoro, Ignacio Melero, Masatoshi Kudo, M. Ho, Ana Matilla, Francesco Tovoli, Jennifer J. Knox, Bassel F. El‐Rayes, Mirelis Rivera Acosta, Jaclyn Neely, Yun Shen, Marina Tschaika, Anthony El-Khoureiry
Ignacio Melero, Thomas Yau, Yoon‐Koo Kang, T.-Y. Kim, Armando Santoro, B. Sangro, Masatoshi Kudo, Ming Hou, Ana Matilla, Francesco Tovoli, Jennifer J. Knox, Aiwu Ruth He, Bassel F. El‐Rayes, M. Acosta-Rivera, Ho Yeong Lim, S. Soleymani, J. Yao, Jaclyn Neely, M. Tschaika, Chiun Hsu, Anthony B. El-Khoueiry
Ignacio Melero, Anthony B. El-Khoueiry, Thomas Yau, Chiun Hsu, Masatoshi Kudo, Todd S. Crocenzi, Tae‐You Kim, Su Pin Choo, Jörg Trojan, Theodore H. Welling, Yoon‐Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine Dela Cruz, Huanyu Zhao, Bruno Sangro, Tim Meyer
Discussion(0)
No comments yet. Be the first to comment.